J Korean Med Assoc.  2021 Mar;64(3):225-231. 10.5124/jkma.2021.64.3.225.

Updated view on the treatment of chronic obstructive pulmonary disease in Korea

• Kim DK
• Rhee CK

• KMID: 2513994
• DOI: http://doi.org/10.5124/jkma.2021.64.3.225

Abstract

Chronic obstructive pulmonary disease (COPD) is prevalent (13.4% in the population above the age of 40) but less recognized by patients and physicians in Korea. The definition and treatment strategies of COPD have changed with the accumulation of evidence, and the Korean COPD guidelines recommended by the Korean Academy of Tuberculosis and Respiratory Disease have also been updated. This review will cover some important points, that should be considered in the management of stable COPD in clinical practice. COPD is a treatable disease and earlier detection should be emphasized to achieve better clinical benefits in the mild stages. In addition, etiologies other than smoking are critical in the development of COPD. Medical treatment strategies have been updated focusing on the role of long-acting bronchodilators and the updated Korean COPD guidelines include specific Korean situations in the management of COPD.

Keyword

Chronic obstructive pulmonary disease; Guideline; Treatment; 만성폐쇄성폐질환; 진료지침; 치료